Soft Tissue Sarcoma Treatment Market Positioned for Revolutionary Changes by 2034
Market Overview Soft tissue sarcoma (STS) is a rare and heterogeneous group of cancers arising from connective tissues such as muscles, fat, blood vessels, and nerves. Despite its rarity, STS presents a significant clinical challenge due to its aggressive nature, diverse subtypes, and complex treatment requirements. Global Soft Tissue Sarcom